跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
翼弗瑞 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Cenobamate Tablets
Approved
化学药品
Cenobamate Tablets
SK Life Science, Inc.
🇨🇳 National Medical Products Administration
Approval Date
Dec 3, 2025
Approval ID
8pdZGRjDS6j
Company
SK Life Science, Inc.
Type
化学药品
Approval Details
Approval Id
8pdZGRjDS6j
Approval Number
国药准字HJ20250143
Generic Name
西诺氨酯片
Generic Name En
Cenobamate Tablets
Trade Name
翼弗瑞
Drug Type
化学药品
Dosage Form
片剂
Strength
12.5mg
Reg Date
2025-12-03
Expired Date
2030-12-02
Company Name
SK Life Science, Inc.
Production Company Name
Patheon Inc
Company Detail Path
/organization/sk-life-science-inc
Production Company Detail Path
/organization/patheon-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 3, 2025
Approval ID
8pdZGRjDS6j
Type
化学药品
Back to NMPA Approvals